Characterization and partial purification of a novel 36 kDa peripheral myelin protein recognized by the sera of patients with neurological disorders

Journal of Neuroimmunology

Volumn 91, Issue 1-2, 1998, Pages 10-18

  Meléndez Vásquez, Carmen V ^a   Gregson, Norman A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Autoantibody; Myelin; P0 glycoprotein; Peripheral neuropathy; Sequencing

Indexed keywords

AUTOANTIBODY; MONOCLONAL ANTIBODY; MYELIN PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; DEGLYCOSYLATION; EPITOPE MAPPING; HUMAN; HUMAN TISSUE; MOTOR NEURON DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; POLYRADICULITIS; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; BLOTTING, WESTERN; CATTLE; CENTRAL NERVOUS SYSTEM; HUMANS; MYELIN PROTEINS; NERVOUS SYSTEM DISEASES; RATS; RATS, INBRED LEW; RATS, WISTAR; SCIATIC NERVE;

EID: 0032476557     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00102-7     Document Type: Article

References (44)

1. 0 glycoprotein of rat peripheral nerve myelin: tentative identification of cleavage site and evidence for the precursor-product relationship. Neurochem. Res. 15:1990;993-1001.
2. Andreadis A., Gallego M., Nadal-Ginard B. Generation of protein isoform diversity by alternative-splicing: mechanistic and biological implications. Annu. Rev. Cell Biol. 3:1987;207-242.
3. 0. J. Neurosci. Res. 35:1993;46-53.
4. Baillie-Johnson H., Twentyman P., Fox N., Walls G., Workman P., Watson J., Johnson N., Reeve J., Bleehen N. Establishment and characterization of cell lines from patients with lung cancer (predominantly small cell carcinoma). Br. J. Cancer. 52:1985;495-504.
5. 0 protein: evidence of early expression in avians. J. Neurosci. Res. 25:1990;143-151.
6. Bouche P., Moulonguet A., Benyouneschennoufi A., Adams D., Baumann N., Meininger V., Leger J., Said G. Multifocal motor neuropathy with conduction block: a study of 24 patients. J. Neurol. Neurosurg. Psychiatry. 59:1995;38-44.
7. 0 glycoprotein and a synthetic peptide containing the palmitoylation site are both autoacylated. J. Neurochem. 65:1995;1805-1815.
8. 0: assessment and relative occurrence of oligosaccharide structures by serial lectin affinity chromatography of C14-glycopeptides. J. Neurochem. 58:1992;845-853.
9. 0 and 'Y' proteins. J. Neurochem. 34:1980;404-409.
10. Eccleston P., Mirsky R., Jessen K. Spontaneous immortalization Schwann cells in culture:short term cultured Schwann cells secrete growth inhibitory activity. Development. 112:1991;33-42.
11. Ellie E., Vital A., Steck A., Boiron J., Vital C., Julien J. Neuropathy associated with bening anti-myelin-associated glycoprotein IgM gammopathy. Clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases. J. Neurol. 243:1996;34-43.
12. Gregson N., Hall S., Hughes R. Anti-nerve antibodies in chronic idiopathic polyradiculoneuropathy. J. Neurol. Neurosurg. Psychiat. 55:1992;1214-1215.
13. Griffiths I., Montague P., Dickinson P. The proteolipid protein gene. Neuropathol. Appl. Neurobiol. 21:1995;85-96.
14. 0, and other 19 to 28 kDa glycoproteins in peripheral nerve myelin of mammals and fish with HNK-1 and related antibodies. J. Neurosci. Res. 35:1993;546-558.
15. Hayasaka K., Nanao K., Tahara M., Sato W., Takada G., Mjura M., Uyemura K. Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral-myelin. Biochem. Biophys. Res. Commun. 180:1991;515-518.
16. Hayes J., Kerr L., Cronshaw A. Evidence that glutathione S-transferases B1B1 and B2B2 are the products of separate genes and that their expression in human liver is subject to inter-individual variation. Molecular relationships between the B1 and B2 subunits and other alpha class glutathione S-transferases. Biochem. J. 264:1989;437-445.
17. Hartung H., Pollard J., Harvey G., Toyka K. Immunopathogenesis and treatment of Guillain-Barré Syndrome: Part I. Muscle Nerve. 18:1995;137-153.
18. Hartung H., Pollard J., Harvey G., Toyka K. Immunopathogenesis and treatment of Guillain-Barré Syndrome: Part II. Muscle Nerve. 18:1995;154-164.
19. 0 glycoprotein: identification of the site phosphorylated in vivo by endogenous protein kinases. J. Neurochem. 64:1995;902-907.
20. Hughes, R.A.C., 1990. Guillain-Barré Syndrome. Springer-Verlag, London.
21. 0 glycoprotein of peripheral nerve myelin. Can. J. Biochem. 58:1980;913-921.
22. Lees, M., Brostoff, S., 1984. Proteins of myelin. In: Morell, P. (Ed.), Myelin, 2nd edn. Plenum, New York, pp. 197-217.
23. 0 proteins in the avian peripheral nerve. Neurochem. Res. 20:1995;269-278.
24. Lemke G., Axel R. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell. 40:1985;501-508.
25. Lemke G., Lamar E., Patterson J. Isolation and analysis of the gene encoding peripheral myelin protein zero. Neuron. 1:1988;73-83.
26. 0 protein and 2′-3′-cyclic nucleotide 3′-phosphodiesterase activity in the peripheral nerve and subcellular fractions of the Trembler mouse. J. Neurochem. 42:1984;810-818.
27. Linington C., Waehneldt T. The glycoprotein composition of peripheral nervous system myelin subfractions. J. Neurochem. 36:1981;1528-1535.
28. Nobile-Orazio E., Manfredini E., Carpo M., Meucci N., Monaco S., Ferrari S., Bonetti B., Cavaletti G., Gemignani F., Durelli L., Barbieri S., Allaria S., Sgarzi M., Scarlato G. Frequency and clinical correlate of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann. Neurol. 36:1994;416-424.
29. 0-related glycoprotein in motor neuron disease. J. Neuroimmunol. 53:1994;143-151.
30. Norton W., Poduslo S. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21:1973;1171-1191.
31. 0 protein of peripheral nerve myelin. Neurochem. Res. 12:1987;377-384.
32. Obi T., Kusunoki S., Takatsu M., Mizoguchi K., Nishimura Y. IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polyasialogangliosides. Acta Neurol. Scand. 86:1992;215-218.
33. Olmsted J., Carlson K., Klebe R., Ruddle F., Rosenbaum J. Isolation of microtubule protein from cultured mouse neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A. 65:1970;129-136.
34. Pedraza L., Frey A., Hempstead D., Colman D., Salzer J. Different expression of MAG isoforms during development. J. Neurosci. Res. 29:1991;141-148.
35. Schagger H., von Jagow G. Tricine-sodium dodecyl sulphate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
36. Snipes G., Suter U. Molecular anatomy and genetics of myelin proteins in the peripheral nervous system. J. Anat. 186:1995;483-494.
37. Snipes G., Suter U., Shooter E. Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J. Neurochem. 61:1993;1961-1964.
38. Snipes G., Suter A., Welcher A., Shooter E. Characterization of a novel peripheral nervous system myelin protein PMP-22/SR13. J. Cell Biol. 117:1992;225-238.
39. Uyemura K. Functional glycoproteins expressed in Schwann cell membrane. Neurosci. Res. 16:1993;9-13.
40. van den Berg L., Sadiq S., Thomas F., Latov N. Characterization of HNK-1 bearing glycoproteins in human peripheral nerve myelin. J. Neurosci. Res. 25:1990;295-299.
41. van Noort J., El Ouagmiri M., Boon J., van Sechel A. Fractionation of central nervous system myelin proteins by reversed-phase high-performance liquid chromatography. J. Chromatogr. B. 653:1994;155-161.
42. Wiggins R., Benjamins J., Morell P. Appearance of myelin proteins in rat sciatic nerve during development. Brain Res. 89:1975;99-106.
43. Willison H. Antiglycolipid antibodies in peripheral neuropathy - fact or fiction. J. Neurol. Neurosurg. Psychiatry. 57:1994;1303-1307.
44. Willison H., Veitch J. Immunoglobulin subclass distribution and binding characteristic of anti-GQ1b antibodies in Miller-Fisher syndrome. J. Neuroimmunol. 50:1994;159-165.